SERA · Sera Prognostics, Inc. · Financials
Market Cap
$80.08M
Shares
39.45M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$81K
+5.2%
FY2025
Net Income
-$31.93M
+2.9%
FY2025
Gross Margin
-102.47%
-96pp
FY2025
Operating Margin
-45066.67%
+2511.2pp
FY2025
Diluted EPS
-$0.67
+32.3%
FY2025
Operating Cash Flow
-$25.62M
-80.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $70K | $81K | $77K | $306K | $268K | $82K | $25K | |
| $175K | $164K | $82K | $210K | — | — | — | |
| -$105K | -$83K | -$5000 | $96K | — | — | — | |
| — | -102.47% | -6.49% | 31.37% | — | — | — | |
| $13.02M | $13.17M | $14.73M | $15.23M | $14.24M | $11.02M | $7.78M | |
| $7.51M | $6.55M | $5.77M | $8.35M | $14.7M | $10.33M | $3.65M | |
| $16.66M | $16.7M | $16.13M | $16.34M | $16.78M | $14.09M | $6.56M | |
| $116K | $116K | $19K | — | — | — | — | |
| $871K | $940K | $833K | $900K | $756K | $659K | $895K | |
| $37.37M | $36.59M | $36.71M | $40.13M | $45.92M | $35.48M | $18M | |
| -$37.3M | -$36.5M | -$36.64M | -$39.82M | -$45.65M | -$35.4M | -$17.97M | |
| — | -45066.67% | -47577.92% | -13013.4% | -17034.33% | -43164.63% | -71884% | |
| -$36.43M | -$35.56M | -$35.8M | -$38.92M | -$44.9M | -$34.74M | -$17.08M | |
| $7000 | $9000 | $28K | $55K | — | — | — | |
| $4.07M | $4.59M | $3.77M | $3.63M | $1.53M | $1.13M | -$38K | |
| — | -$31.93M | -$32.9M | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$33.23M | -$31.93M | -$32.9M | -$36.24M | -$44.19M | -$35.01M | -$19.85M | |
| — | -39417.28% | -42724.68% | -11843.79% | -16487.31% | -42693.9% | -79392% | |
| -$33.43M | -$31.73M | -$32.82M | -$35.28M | -$44.98M | -$35.19M | -$19.85M | |
| USD/shares | -$0.66 | -$0.67 | -$0.99 | -$1.16 | -$1.43 | -$2.33 | -$12.76 |
| USD/shares | -$0.66 | -$0.67 | -$0.99 | -$1.16 | -$1.43 | -$2.33 | -$12.76 |
| shares | — | 47.66M | 33.16M | 31.2M | 30.94M | 15M | 1.56M |
| shares | — | 47.66M | 33.16M | 31.2M | 30.94M | 15M | 1.56M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.25×
EV/EBIT
—
Peer median 14.38×
P/E (TTM)
—
Peer median 24.42×
Peer medians compare against the 75 similar-size Medical Devices companies (of 150 listed).
Key facts
CIK
1534969
CUSIP
81749D107
13F (30d)
13 filings
13 filers
Visit website
Investor relations